retatrutide patent eli lilly Lilly's $1 Trillion Boom: Inside Dave Ricks' Weight-Loss Bet Reminder: Eli Lilly Has Been

It runs for 80 weeks (the longest in the program), enrolls a general obesity population without type 2 diabetes, and is designed to be the direct apples-to-apples analogue of SURMOUNT-1 (tirzepatide) and STEP-1 (semaglutide)

The common side effects of retatrutide are: Nausea Vomiting Diarrhea Constipation Fatigue Abdominal discomfort Early satiety Injection site reactions Increased heart rate Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Liver problems Severe gastrointestinal issues Major depressive disorder Suicidal ideal Changes in mood and behavior Pancreatitis Low blood sugar levels (hypoglycemia) Cardiac arrhythmias The drug is still not FDA-approved and contraindications have not yet been determined

To prevent future buildup, consider installing water softeners to treat the mineral problem at the source

Summer Months (June September) Warmer months bring their own logistics